Aducanumab: A Deep Dive into BIIB037 and its Impact The compound, initially known as BIIB037, represents a complex endeavor to treat mild Alzheimer's condition. Developed by Biogen, the treatment works by targeting https://tamzinbgis092738.mpeblog.com/74477986/text